Gain Therapeutics (GANX) Net Equity Issued and Repurchased (2020 - 2026)
Gain Therapeutics (GANX) reported Net Equity Issued and Repurchased of $2,063 for Q1 2026, down 100.0% from $5.64 million a year earlier and down 99.9% from the prior quarter.
Powered by 
Analysis
Gain Therapeutics (GANX) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
For FY2025, Gain Therapeutics posted Net Equity Issued and Repurchased of $3.22 million.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of 611.1% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $113,800 in FY2024 (-97.1%), $3.9 million in FY2023 and $42.63 million in FY2021.
- Five-year quarterly Net Equity Issued and Repurchased spans a low of -$5.12 million in Q3 2025 and a high of $16.6 million in Q2 2025.
- Per Business Quant data, the three quarters before Q1 2026 came in at $3.18 million (Q4 2025), -$5.12 million (Q3 2025) and $16.6 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | -1.60 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | -9.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -714.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | -1.20 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -346.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | - |
| 10 | Gain Therapeutics | 54.89 Mn | -4.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2,063.00 |
| Dec 31, 2025 | 3.43 Mn |
| Sep 30, 2025 | -5.12 Mn |
| Jun 30, 2025 | 2.67 Mn |
| Mar 31, 2025 | 2.49 Mn |
| Dec 31, 2024 | -1.00 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 13,575.00 |
| Mar 31, 2024 | 157,936.00 |
| Dec 31, 2023 | 752,767.00 |
| Sep 30, 2023 | 157,103.00 |
| Jun 30, 2023 | 2.22 Mn |
| Mar 31, 2023 | 770,520.00 |
| Dec 31, 2021 | 12,216.00 |
| Mar 31, 2021 | 52.53 Mn |
| Jun 30, 2020 | -10,554.00 |
| Mar 31, 2020 | 1.11 Mn |
API Access
Gain Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GANX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "GANX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=GANX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();